Guía de atención de la lepra

  • Ministerio de la Protección Social Ministerio de la Protección Social
  • Programa de Apoyo a la Reforma de Salud Programa de Apoyo a la Reforma de Salud
  • Universidad Nacional de Colombia Universidad Nacional de Colombia
  • Instituto de Investigaciones Públicas Instituto de Investigaciones Públicas

Resumen

La lepra es una enfermedad infecciosa con probable susceptibilidad genética y de larga evolución, que se transmite por el contacto directo y prolongado con pacientes de las formas abiertas (bacilíferos) y afecta múltiples órganos causando secuelas en ocasiones irreversibles. La actualización de la Guía de atención de la lepra constituye un conjunto de recomendaciones asistenciales que intentan proporcionar información acerca del diagnóstico y tratamiento del paciente con lepra.

 

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Ministerio de la Protección Social , Ministerio de la Protección Social

Ministerio de la Protección Social

Programa de Apoyo a la Reforma de Salud, Programa de Apoyo a la Reforma de Salud

Programa de Apoyo a la Reforma de Salud

Universidad Nacional de Colombia, Universidad Nacional de Colombia

Universidad Nacional de Colombia

Instituto de Investigaciones Públicas, Instituto de Investigaciones Públicas

Instituto de Investigaciones Públicas

Referencias bibliográficas

WHO. Expert Committee on Leprosy, 7th Report, 1998: 1-43.

Faizal M. La lepra. Universidad Nacional de Colombia. Servicio de biblioteca virtual. www.unal.edu.co

Guerrero M, Arias MT, Garcés MT, León CI. Desarro- llo y aplicación de una prueba de RCP para detectar la infección subclínica por Mycobacterium leprae. Rev Panam Salud Pública; 11(4); 2002: 228-233. https://doi.org/10.1590/S1020-49892002000400004

World Health Organization. Chemotherapy of le- prosy. Disponible en: http:// www.who.int/lep/reports/ trs847. Pdf. Acceso el 5 de julio de 2004.

SIVIGILA. Boletín epidemiológico. 2004.

Hastings RC, editor. Leprosy. Edinburgh: Churchill Li- vingstone; 1994.

Thalhari S, Garrido N R. Hanseníase. Instituto supe- rior de estudos da Amazõnia 1989.

Jacobson RR, Krahenbuhl JL. Leprosy. Lancet 1999; 353: 655-60. https://doi.org/10.1016/S0140-6736(98)06322-3

Ottenhoff THM. Immunology of leprosy: lesson from and for xxx rosy [editorial]. Int J Lepr 1994; 62: 108- 21.

Meyer CG, May J Stark K. Human leukocyte antigens in tuberculosis and leprosy. Trends Microbiol 1998; 6: 148-53. https://doi.org/10.1016/S0966-842X(98)01240-2

Ridley D. Pathogenesis of leprosies and related diseases. Butterw & co 1998.

Freeedman VH, Weinstein DE, Kaplan G. How Mycobacterium leprae infects peripheral nerves. Lepr Rev 1999; 70: 136-9. https://doi.org/10.5935/0305-7518.19990017

Charosky CB. Cardama JE. Neuropathies in hansen's disease. Int J Leprosy 1983: 51: 576-86.

Brazis PW. Masdeu JC, Biller J. Localization in clinical neurology. Second edition. Little, Brown and Com- pany; 1990; 3.

Low PH. Disease of peripheral nerves in clinical neurology. Lippincott- Raven Publisher. 1994.

Liwen D. Diagnostic exploration of enlarged peripheral nerves in suspected cases of leprosy: An analysis of 55. cases. Lepr Rev 1992; 63: 141-4. https://doi.org/10.5935/0305-7518.19920018

Ebenezer GJ, Suneetha S, Mohandas R Arunthathi S. Multibacillary nerve histology in clinically diagnosed dordeline tuberculoid leprosy patients. Int J Lepr 1996; 64: 311-5.

Rameshh G., Ramana P.V. et al. Two unusual nerve abscesses - lepromatous leprosy and pure neural le- prosy: case reports. Lepr Rev 1996; 67: 217-221. https://doi.org/10.5935/0305-7518.19960023

Lienhardt C, Fine P E M. Type 1 reaction, neuritis and disability in Leprosy: what is the current epidemiological situation? Lepr Rev 1994; 65: 190-203. https://doi.org/10.5935/0305-7518.19940002

Job CK, jayakumar J, Williams DL, Gillis TP. Role of polymerase chain reaction in the diagnosis of early le- prosy. Int J Lepr Other Mycobact Dis 1997; 65: 461- 464.

Santos AR, De Miranda AB, Sarno EN, Suffys PN, Degrave WM. Use of RCP - mediated amplification of Mycobacterium leprae DNA in different types of clinical samples for the diagnosis of leprosy. J Med Microbiol 1993;39: 298-304;43. https://doi.org/10.1099/00222615-39-4-298

Wolcott MJ. Advances in nucleic acid-based detection methds. Cliun Microbiol Rev 1992; 5: 370-386,44.

https://doi.org/10.1128/CMR.5.4.370

Erlich HA, Gelfand DH, Saiki RK. Specific DNA amplification. Nature 1988; 331: 461-462,45. https://doi.org/10.1038/331461a0

Williams D, Gillis T. Molecular Detection of Drug Resistance in Mycobacterium Leprae. Lepr Rev 2004; 75: 118-130. https://doi.org/10.47276/lr.75.2.118

Jennekens F, Schinkel A. Neurological examination of patients suffering from leprosy: is it worthwhile? Lepr Rev 1992; 63: 269-73. https://doi.org/10.5935/0305-7518.19920032

Van Brakel W. Shute J, Dixon J, Arzet H. Evaluation of sensibility in leprosycomparison of various clinical methods. Lepr Rev 1994; 65: 106-21. https://doi.org/10.5935/0305-7518.19940010

Mahajan PM; DG Jogaikar, Mehta JM. A study of pure neuritic leprosy: clinical experience. Indian J Lepr 1996; 68 (2): 137-141.

Menicucci LA, Miranda A, Gomes Antunes SL, Rodríguez M. Microscopic Leprosy Skin Lesions In Primary Neuritis Leprosy. Journal of the American Academy of Dermatology 2004; 52: 648-652. https://doi.org/10.1016/j.jaad.2004.11.068

Britton W, Lockwood D. Leprosy. Lancet 2004; 363: 1209-19. https://doi.org/10.1016/S0140-6736(04)15952-7

Moschella S. An update on the diagnosis and treatment of leprosy. Journal of the American Academy of Dermatology. 2004; 51: 417-26. https://doi.org/10.1016/j.jaad.2003.11.072

Honore N, Perrani E, Telenti A, Grosset J, Cole ST. A simple and rapid technique for the detection of ri- fampin resistance in Mycobacterium leprae Int J Lepr Other Mycobact Dis 1993; 61: 600-604.

Cambau E, Perani E, Guillemin I, Jamet P, Ji B. Multi- drug resístance to dapsone, rifampicin and ofloxacin in mycobacterium leprae. Lancet 1997; 349: 103-104. https://doi.org/10.1016/S0140-6736(05)60888-4

Richardus J, Nicholls P. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up. Inter- national Journal of Epidemiology 2004; 33: 337-343. https://doi.org/10.1093/ije/dyg225

Galvis V, Bustamante M. Guía de atención de la lepra. Ministerio de salud Colombia; dirección general de promoción y prevención. 1999.

Leiker D.L., McDougall A.C. Guia técnico Baciloscopia Da Hanseníase Talmilep, 2da edición, 1987.

Moet FJ, Meima A, Oskam L, Richardus JH. Risk factors for the development of clinical leprosy among contacts, and their relevance for targerted intervention. Lepra Review, 2004; 34: 310-326. https://doi.org/10.47276/lr.75.4.310

Shumin C, Zhang L, Diagchang L, Bing L. Should contanct examination in a low endemic situation of leprosy continue? International Journal of leprosy 2003; 71 (2): 95-100. https://doi.org/10.1489/1544-581X(2003)071<0095:SHCEIA>2.0.CO;2

Douglas J T, Celliona R V, Fajardo T T, Abalos R M. Prospective study of serological conversión as a risk factor for development of leprosy among household contacts. Clinical and diagnostic laboratory immunology 2004; 11 (5): 897-900. https://doi.org/10.1128/CDLI.11.5.897-900.2004

Ji B. Why Multidrug Theraphy for multibacillary leprosy can be shortened for 12 months. Lepra Review 1998; 69: 106 - 109. https://doi.org/10.5935/0305-7518.19980009

Britton W J, Lockwood D. Leprosy. Lancet 2004; 363: 1209 - 1219 https://doi.org/10.1016/S0140-6736(04)15952-7

Normas tecnicas e procedimentos para utilizacao dos esquemas de poliquimioterapia No tratamento Da Hanseníase. Ministerio da Saúde Secretaria Nacional Divisão Nacional de Programas Especiais De SaúdeDivisão Nacional De Dermatologia Sanitária. Brasília Brasil.

Klioze A, Ramos-Caro F. Visceral Leprosy. International Journal Of Dermatology 2000; 39: 641 - 658. https://doi.org/10.1046/j.1365-4362.2000.00860.x

Kontochristopoulos G, Kyriakis K, Symeonidou S. Squamous cell carcinoma in chronic trophic ulcers of leprosy patients. Journal Of The European Academy Of Dermatology And Venereology 2000; 14: 222-236. https://doi.org/10.1046/j.1468-3083.2000.00061-8.x

John S, Roul RK, Anderson GA. Cancer associated with Leprosy. Indian Journal Of leprosy 1994; 66 (3): 321-325.

Bobhate SK, Madankar ST, Parate SN, Choudhary RK, Kumbhalkar DT. Malignant transformation of plantar ulcers in leprosy. Indian Journal Of Leprosy 1993; 65 (3): 297- 303.

Richardus JH, Smith TC. Squamous cell carcinoma in chronic ulcers in leprosy: a review of 38 consecutive cases 1991; 62 (4): 381-388. https://doi.org/10.5935/0305-7518.19910044

Gift N, Geetha J, Joseph R. Relapses in multibacillary patients treated with multidrug therapy until smear negative: Findings after twenty years. International Journal Of Leprosy 2004; 72 (1): 1 - 7 https://doi.org/10.1489/1544-581X(2004)072<0001:RIMPTW>2.0.CO;2

Gillis W. Psychiatric aspects of Hansen disease. J Clin Psychiatry. Dec 1987;48(12): 470-79.

Bharath S, Shamasundar C. Correlates of Psychiatric morbidity in patients w

ith leprosy. Indian J Lepr. Jul 2001; 73 (3): 217-28.

Cómo citar
1.
Ministerio de la Protección Social, Programa de Apoyo a la Reforma de Salud, Universidad Nacional de Colombia, Instituto de Investigaciones Públicas I de IP. Guía de atención de la lepra. Med. Lab. [Internet]. 1 de julio de 2011 [citado 23 de mayo de 2022];17(7-8):359-88. Disponible en: https://medicinaylaboratorio.com/index.php/myl/article/view/365
Publicado
2011-07-01
Sección
Microbiología

Artículos más leídos del mismo autor/a